title: Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma.
authors.affiliation: Department of Surgery B, Tel Aviv Medical Center, Tel Aviv University, Sackler School of Medicine, Petach Tikvah, Israel.
authors.forename: H J
authors.initials: HJ
authors.lastname: Merhav
authors.forename: M
authors.initials: M
authors.lastname: Landau
authors.forename: A
authors.initials: A
authors.lastname: Gat
authors.forename: E
authors.initials: E
authors.lastname: Gazit
authors.forename: M
authors.initials: M
authors.lastname: Baratz
authors.forename: A
authors.initials: A
authors.lastname: Bialy-Golan
authors.forename: F
authors.initials: F
authors.lastname: Konikof
authors.forename: S
authors.initials: S
authors.lastname: Bril
authors.forename: R
authors.initials: R
authors.lastname: Nakache
mesh_terms: D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000601:surgery*; D003520:Cyclophosphamide / Q000627:therapeutic use; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000628:therapy*; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000150:complications* / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone